Georgia Shell ‘23 pitched Elevance Health (NYSE: ELV) on October 24, 2022. Elevance Health is the largest health insurer in the United States in terms of medical membership, serving over 47 million medical members through its affiliated health plans. Elevance Health was founded in 1946 and is headquartered in Indianapolis, Indiana. Georgia’s investment thesis was focused on increasing membership, growing investments in technology, and strategic acquisitions as strong growth catalysts for the company. Health care companies have held their own this year against a challenging macroeconomic environment. Given the size of the aging population and the increase in chronic diseases, there is reason to believe that health care will be even more indispensable. As the stock jumped after the Q3 2022 earnings release, Georgia proposed a buy-write strategy. SMIF voted to buy 100 shares of Elevance Health (ELV) at market price and simultaneously sell 1 ELV January 520 call, funded through the sale of Abbott Laboratories (ABT) and Comcast (CMCSA). In order to increase active risk in the Health Care Sector, SMIF also voted to buy 140 shares of the Health Care Select Sector SPDR (XLV) at market price, funded with cash in the portfolio.